Acute effects of low density lipoprotein apheresis on metabolic parameters of apolipoprotein B

Journal of Lipid Research

Volumn 41, Issue 10, 2000, Pages 1596-1603

  Parhofer, Klaus G ^a   Barrett, P Hugh R ^b   Demant, Thomas ^a   Schwandt, Peter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Apheresis; ApoB 100; Compartmental models; Kinetics; Lipoprotein metabolism; Non steady state kinetics

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN; TRACER; VERY LOW DENSITY LIPOPROTEIN;

ADULT; APHERESIS; ARTICLE; CATABOLISM; CLINICAL ARTICLE; COMPARTMENT MODEL; CORONARY ARTERY DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA; ISOTOPE LABELING; LIPOPROTEIN METABOLISM; LIPOPROTEIN SECRETION; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; STEADY STATE; TREATMENT INDICATION;

EID: 0033775592     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-2275(20)31992-1     Document Type: Article

References (28)

1. Therapeutic effects of LDL apheresis in the prevention of atherosclerosis
2. Effects of weekly LDL apheresis on metabolic parameters of apolipoprotein B in heterozygous familial hypercholesterolemia
3. Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia
4. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes
5. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolemia
6. The HELP LDL Apheresis Multicenter Study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. I. Evaluation of safety and cholesterol lowering effects during the first 12 months
7. Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein-B antibodies
8. Direct determination of human and rabbit apolipoprotein B selectively precipitated with butanol-isopropyl ether
9. Sensitive mass spectrometry techniques for measuring metabolism of human apolipoprotein B in vivo
10. Tracer to tracee ratio for analysis of stable isotope tracer data: Link with radioactive kinetic formalism
11. Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, itermediate density lipoproteins, and low density lipoproteins
12. Sensitive methods to study human apolipoprotein B metabolism using stable isotope-labeled amino acids
13. Kinetics of apolipoprotein B in normal and hyperlipidemic man: Review of current data
14. A preliminary model for human lipoprotein metabolism in hyperlipoproteinemia
15. Parameter and structural identifiability concepts and ambiguities: A critical review and analysis
16. Effect of pravastatin on metabolic parameters of apolipoprotein-B in patients with mixed hyperlipoproteinemia
17. Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy
18. Upregulation of cholesterol synthesis after acute reduction of low density lipoprotein by apheresis in normocholesterolaemic subjects: Evidence for a threshold effect
19. Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes
20. Regulation of hepatic secretion of apolipoprotein B containing lipoproteins information obtained from cultured liver cells
21. No evidence for feedback inhibition of hepatic apolipoprotein-B (apo-B) production after extracorporeal low density lipoprotein precipitation as determined by [1-C-13]leucine infusion in normal volunteers
22. Non-steady-state studies of low-density lipoprotein turnover in familial hypercholesterolemia
23. Non-steady-state kinetics of low density lipoproteins in man - Studies after plasma exchange in healthy subjects and patients with familial hypercholesterolaemia
24. LDL apolipoprotein B metabolism: Comparison of two methods to establish kinetic parameters
25. Low-density lipoprotein-apolipoprotein B metabolism following apheresis: Simulation studies of mass changes and tracer kinetics
26. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy
27. Metabolic basis of primary hypercholesterolemia
28. 3H]leucine tracer